Consortia biotechnology (Q10151): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Removed claim: co-financing rate (P837): 52.8899998922312 percent) |
||||||
Property / co-financing rate | |||||||
| |||||||
Property / co-financing rate: 52.8899998922312 percent / rank | |||||||
Revision as of 14:37, 19 March 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | Consortia biotechnology |
Project in Czech Republic financed by DG Regio |
Statements
3,582,640.07 Czech koruna
0 references
6,773,757.0 Czech koruna
0 references
1 January 2017
0 references
31 August 2019
0 references
EPS biotechnology, s.r.o.
0 references
68604
0 references
Cílem projektu je vyvinout biotechnologické preparáty postavené na principu funkčních mikrobiálních konsorcií za účelem technologicky využít pozitivních vlastností, jimiž disponují z hlediska snazší adaptace, ochrany před letálními faktory, rychlejšího využití substrátu, případně schopnostem propůjčit některým potravinářským produktům zcela jiné a unikátní organoleptické vlastnosti. Projekt bude pokrývat dvě jednoznačně definované oblasti ? (1) biotechnologie ŽP a (2) kvasné technologie. a. (Czech)
0 references
The aim of the project is to develop biotechnology-based preparations based on the principle of viable microbial consortia to take advantage of the positive qualities that they enjoy in terms of easier adaptation, protection from lethal factors, faster use of the substrate, or ability to give certain food products entirely different and unique organoleptic characteristics. Will the project cover two clearly defined areas? (1) from the RUs and (2) quasi technologies. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_018/0005089
0 references